Research Overview
Helen’s interest is in early-onset T2D (T2D before 39 years of age) which is associated with hypertension, hyperlipidemia and a severe cardio-metabolic phenotype. Helen hopes that her research will help those with early-onset T2D.
“Those with early-onset T2D are predominantly female, poor and from minority racial/ethnic groups. Females are disproportionately affected by early-onset T2D and this has major implications for reproductive health and future pregnancies.”